Dimerix and its kidney drug is on track but with results of its phase III trial not due for years, a few more twists and turns are likely.

Oversleeping may be more dangerous than short sleep, increasing risks of cognitive decline, depression, heart disease, and ...

The results of the MIROCALS randomized clinical trial have shown that adding low-dose interleukin-2 (IL2LD) to standard ...

A clinical trial has found that low-dose interleukin-2 is safe and may significantly extend survival in people with motor ...

New research by scientists at the University of Toronto and the Structural Genomics Consortium has deepened our understanding ...

There are many natural ways you can help ease PCOS symptoms, like ingesting herbs and making lifestyle changes, instead of ...

Donald Trump announced plans to sign an executive order to slash prescription drug prices in the U.S. by at least 30%, ...

Yet, despite more than 20 years of study, the sweet receptor’s precise architecture remained elusive, even as scientists ...

Effective mucosal immunity in the intestine involves a fine balance between tolerance of the microbiome, recognition and elimination of pathogens, and inflammatory tissue injury. The anti-inflammatory ...

A new study uncovers how fine-tuning the interactions between two distinct network-forming species within a soft gel enables programmable control over its structure and mechanical properties. The ...

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

The Nintendo Switch 2 is real and it's launching in June! After literally years of unverified rumors, dubious leaks and copious amounts of online speculation, Nintendo revealed its next-generation ...